Nektar Therapeutics Inc. (NKTR)
Market Open
11 Sep, 16:18
$
69. 65
-1
-1.4096%
$
2.13B Market Cap
- P/E Ratio
- Div Yield
150,054 Volume
-0.72 Eps
$ 70.65
Previous Close 
Want to track NKTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
What Makes Nektar (NKTR) a New Buy Stock
Nektar (NKTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks | 2 years ago
Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript
Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript
Seekingalpha | 2 years ago
Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top
Nektar (NKTR) reports a wider-than-expected loss in the second quarter of 2024 while revenues beat estimates. Stock falls in after-hours trading.
Zacks | 2 years ago
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.27 per share a year ago.
Zacks | 2 years ago
